Butensky & Cohen Financial Security’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-190
Closed -$11K – 75
2017
Q2
$11K Hold
190
– – 0.01% 100
2017
Q1
$10K Hold
190
– – 0.01% 102
2016
Q4
$11K Hold
190
– – 0.01% 98
2016
Q3
$10K Hold
190
– – 0.01% 95
2016
Q2
$14K Sell
190
-40
-17% -$2.83K 0.01% 83
2016
Q1
$15K Hold
230
– – 0.01% 92
2015
Q4
$16K Hold
230
– – 0.02% 96
2015
Q3
$14K Hold
230
– – 0.01% 96
2015
Q2
$15K Buy
+230
New +$15.2K 0.02% 95

Other funds holding BMY

Butensky & Cohen Financial Security's BMY Position: Q3 2017 in Review

Butensky & Cohen Financial Security sold out of Bristol-Myers Squibb (BMY) in Q3 2017, closing a stake of 190 shares — an estimated $11K sold.

Butensky & Cohen Financial Security first reported a position in BMY in Q2 2015 and held it in 9 quarters. The position peaked at $16K in Q4 2015. 1,642 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

  • Butensky & Cohen Financial Security reported no remaining Bristol-Myers Squibb position as of Q3 2017 after selling out during the quarter.
  • Butensky & Cohen Financial Security sold 190 Bristol-Myers Squibb shares in Q3 2017, an estimated $11K.
  • Butensky & Cohen Financial Security first reported a position in Bristol-Myers Squibb in Q2 2015 and held it in 9 quarters.
  • Butensky & Cohen Financial Security's Bristol-Myers Squibb position peaked at $16K in Q4 2015.
  • 1,642 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on Butensky & Cohen Financial Security's 13F filing for Q3 2017, filed 20 Oct 2017.